From: Improvement of long-term clinical outcomes by successful PCI in the very elderly women with ACS
Variables | Univariate regression | Multivariate regression | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age | 1.137 | 1.031–1.253 | 0.01 | 1.039 | 0.941–1.148 | 0.444 |
STEMI | 2.310 | 1.361–3.919 | 0.002 | 1.944 | 1.11–3.403 | 0.02 |
log NT-proBNP | 2.073 | 1.339–3.211 | 0.001 | 1.689 | 1.029–2.773 | 0.038 |
ALT (U/L) | 1.009 | 1.002–1.015 | 0.006 | 1.003 | 0.997–1.009 | 0.410 |
Creatinine (umol/L) | 1.009 | 1–1.017 | 0.048 | 1.002 | 0.992–1.011 | 0.721 |
LVEF ≥ 50% | 0.233 | 0.128–0.426 | < 0.001 |  |  |  |
Primary PCI | 2.780 | 1.632–4.737 | < 0.001 |  |  |  |
Aspirin | 0.492 | 0.275–0.878 | 0.016 | 0.784 | 0.392–1.57 | 0.493 |
P2Y12 receptor antagonist | 0.147 | 0.075–0.288 | < 0.001 | 0.119 | 0.051–0.278 | < 0.001 |
β-blocker | 0.422 | 0.248–0.718 | 0.001 | 0.452 | 0.254–0.805 | 0.007 |